STOCK TITAN

[Form 4] AEHR TEST SYSTEMS Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

AEHR Test Systems reported insider transactions by its President and CEO/Director. On 10/13/2025 and 10/14/2025, the reporting person had F-code share withholdings to cover taxes upon vesting of equity awards: 3,791 shares at $25.52 and 3,448 shares at $27.29. The filer notes this does not represent a sale.

Following these transactions, beneficial ownership stood at 261,914 shares direct and 291,628 shares indirect by Trust. The direct amount reported includes shares subject to unvested restricted stock units and unvested restricted shares.

AEHR Test Systems ha riportato operazioni insider da parte del proprio Presidente e CEO/Director. Il 13/10/2025 e il 14/10/2025, la persona che segnala ha trattenuto azioni F-code per coprire le tasse al vesting dei premi azionari: 3.791 azioni a $25,52 e 3.448 azioni a $27,29. Il dichiarante osserva che ciò non rappresenta una vendita.

A seguito di queste operazioni, la proprietà beneficiante era di 261.914 azioni diretta e 291.628 azioni indiretta per trust. La quantità diretta riportata include azioni soggette a unità azionarie non vestite e azioni non vestite soggette a restrizioni.

AEHR Test Systems informó transacciones de insider por parte de su Presidente y CEO/Director. En 13/10/2025 y 14/10/2025, la persona reportante tenía retención de acciones F-code para cubrir impuestos al vesting de premios sobre acciones: 3.791 acciones a $25,52 y 3.448 acciones a $27,29. El presentante señala que esto no representa una venta.

Tras estas transacciones, la titularidad beneficiosa era de 261.914 acciones directas y 291.628 acciones indirectas por fideicomiso. La cantidad directa reportada incluye acciones sujetas a unidades de acciones restringidas no vestidas y acciones restringidas no vestidas.

AEHR Test Systems는 사장 겸 CEO/이사인 내부자 거래를 보고했습니다. 2025년 10월 13일2025년 10월 14일에 보고자가 과세를 충당하기 위해 주식 수여의 vesting 시점에 대비한 F-code 주식 보유분를 행사했습니다: 3,791주를 $25.52에, 그리고 3,448주를 $27.29에. 신고자는 이것이 매도가 아님을 명시합니다.

이 거래 이후, 실질적 소유지는 261,914주를 직접 보유하고 291,628주를 신탁에 의한 간접 보유하게 되었습니다. 직접 보유액에는 취득일 전의 vesting되지 않은 제한주식단위(RSU) 및 vesting되지 않은 제한주식이 포함됩니다.

AEHR Test Systems a déclaré des transactions d'initiés par son Président et PDG/Directeur. Le 13/10/2025 et le 14/10/2025, la personne déclarante a détenu des actions F-code pour couvrir les impôts lors de la mise en vesting des attributions d'actions: 3 791 actions à $25,52 et 3 448 actions à $27,29. Le déclarant précise que cela ne représente pas une vente.

Suite à ces transactions, la propriété bénéficiaire se montait à 261 914 actions directes et 291 628 actions indirectes par fiducie. Le montant direct déclaré inclut des actions soumises à des unités d’actions restreintes non vesties et des actions restreintes non vesties.

AEHR Test Systems meldete Insider-Transaktionen durch seinen Präsidenten und CEO/Director. Am 13.10.2025 und 14.10.2025 hatte die meldende Person F-code Aktienhaltungen, um Steuern beim Vesting von Aktienzuteilungen abzudecken: 3.791 Aktien zu $25,52 und 3.448 Aktien zu $27,29. Der Meldende weist darauf hin, dass dies kein Verkauf ist.

Nach diesen Transaktionen lag das wirtschaftliche Eigentum bei 261.914 Aktien direkt und 291.628 Aktien indirekt durch Treuhand. Der direkt gemeldete Betrag umfasst Aktien, die unvested Restricted Stock Units und unvested Restricted Shares unterliegen.

AEHR Test Systems أبلغت عن معاملات داخلية من قبل رئيسها والمدير التنفيذي/المُدير. في 13/10/2025 و14/10/2025، كان الشخص المبلغ لديه حيازات أسهم F-code لتغطية الضرائب عند استحقاق منح الأسهم: 3,791 سهم بسعر $25.52 و 3,448 سهم بسعر $27.29. يشير المُبلغ إلى أن هذا لا يمثل بيعاً.

بعد هذه المعاملات، بلغت الملكية المفيدة 261,914 سهمًا مباشرة و 291,628 سهمًا غير مباشرة عبر الثقة. تشمل الحصة المباشرة الأسهم الخاضعة لوحدات أسهم مقيدة غير مُكتملة (غير vestied) والأسهم المقيدة غير المكتملة.

AEHR Test Systems 报告了其总裁兼首席执行官/董事的内部人交易。于2025/10/132025/10/14,申报人持有用于覆盖股票奖励归属税款的F-code 股票抵扣:共3,791股,价格为$25.52,以及3,448股,价格为$27.29。申报人指出这并不构成出售。

这些交易之后,受益所有权直接为261,914股,间接通过信托为291,628股。直接持有额包含尚未归属的受限股票单位和尚未归属的受限股票。

Positive
  • None.
Negative
  • None.

Insights

Analyzing...

AEHR Test Systems ha riportato operazioni insider da parte del proprio Presidente e CEO/Director. Il 13/10/2025 e il 14/10/2025, la persona che segnala ha trattenuto azioni F-code per coprire le tasse al vesting dei premi azionari: 3.791 azioni a $25,52 e 3.448 azioni a $27,29. Il dichiarante osserva che ciò non rappresenta una vendita.

A seguito di queste operazioni, la proprietà beneficiante era di 261.914 azioni diretta e 291.628 azioni indiretta per trust. La quantità diretta riportata include azioni soggette a unità azionarie non vestite e azioni non vestite soggette a restrizioni.

AEHR Test Systems informó transacciones de insider por parte de su Presidente y CEO/Director. En 13/10/2025 y 14/10/2025, la persona reportante tenía retención de acciones F-code para cubrir impuestos al vesting de premios sobre acciones: 3.791 acciones a $25,52 y 3.448 acciones a $27,29. El presentante señala que esto no representa una venta.

Tras estas transacciones, la titularidad beneficiosa era de 261.914 acciones directas y 291.628 acciones indirectas por fideicomiso. La cantidad directa reportada incluye acciones sujetas a unidades de acciones restringidas no vestidas y acciones restringidas no vestidas.

AEHR Test Systems는 사장 겸 CEO/이사인 내부자 거래를 보고했습니다. 2025년 10월 13일2025년 10월 14일에 보고자가 과세를 충당하기 위해 주식 수여의 vesting 시점에 대비한 F-code 주식 보유분를 행사했습니다: 3,791주를 $25.52에, 그리고 3,448주를 $27.29에. 신고자는 이것이 매도가 아님을 명시합니다.

이 거래 이후, 실질적 소유지는 261,914주를 직접 보유하고 291,628주를 신탁에 의한 간접 보유하게 되었습니다. 직접 보유액에는 취득일 전의 vesting되지 않은 제한주식단위(RSU) 및 vesting되지 않은 제한주식이 포함됩니다.

AEHR Test Systems a déclaré des transactions d'initiés par son Président et PDG/Directeur. Le 13/10/2025 et le 14/10/2025, la personne déclarante a détenu des actions F-code pour couvrir les impôts lors de la mise en vesting des attributions d'actions: 3 791 actions à $25,52 et 3 448 actions à $27,29. Le déclarant précise que cela ne représente pas une vente.

Suite à ces transactions, la propriété bénéficiaire se montait à 261 914 actions directes et 291 628 actions indirectes par fiducie. Le montant direct déclaré inclut des actions soumises à des unités d’actions restreintes non vesties et des actions restreintes non vesties.

AEHR Test Systems meldete Insider-Transaktionen durch seinen Präsidenten und CEO/Director. Am 13.10.2025 und 14.10.2025 hatte die meldende Person F-code Aktienhaltungen, um Steuern beim Vesting von Aktienzuteilungen abzudecken: 3.791 Aktien zu $25,52 und 3.448 Aktien zu $27,29. Der Meldende weist darauf hin, dass dies kein Verkauf ist.

Nach diesen Transaktionen lag das wirtschaftliche Eigentum bei 261.914 Aktien direkt und 291.628 Aktien indirekt durch Treuhand. Der direkt gemeldete Betrag umfasst Aktien, die unvested Restricted Stock Units und unvested Restricted Shares unterliegen.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Erickson Gayn

(Last) (First) (Middle)
C/O AEHR TEST SYSTEMS
400 KATO TERRACE

(Street)
FREMONT CA 94539

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
AEHR TEST SYSTEMS [ AEHR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
3. Date of Earliest Transaction (Month/Day/Year)
10/13/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/13/2025 F 3,791(1) D $25.52 265,362(2) D
Common Stock 10/14/2025 F 3,448(1) D $27.29 261,914(2) D
Common Stock(3) 291,628 I By Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. This does not represent a sale by the Reporting Person.
2. The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares.
3. RSA with vesting schedule
Remarks:
/s/Chris Siu, Attorney-in-Fact 10/14/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Aehr Test Sys

NASDAQ:AEHR

AEHR Rankings

AEHR Latest News

AEHR Latest SEC Filings

AEHR Stock Data

801.48M
28.21M
5.31%
60.66%
18.86%
Semiconductor Equipment & Materials
Instruments for Meas & Testing of Electricity & Elec Signals
Link
United States
FREMONT